graph Evidence gap map comparisons
atezolizumab based treatmentnivolumab based treatmentpembrolizumab based treatment
atezolizumab alone nivolumab alone pembrolizumab alone
Comparator:  vs placebo;   vs nivolumab plus ipilimumab; 
Risk of bias:  low;   some concerns;   high;  NA;